Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2013
Operating activities
Net income (loss)	$ (11,497)	$ 17,097	$ (1,298)
Less: Income from discontinued operations	0	(19,992)	(4,916)
Loss from continuing operations	(11,497)	(2,895)	(6,214)
Adjustments to reconcile loss from continuing operations to net cash used in operating activities:
Restructuring, severance and other charges	1,482	1,392	1,495
Payments for restructuring, severance and other charges	(1,348)	(1,741)	(6,673)
Litigation Settlement, Expense	203	0	1,664
Payments for legal settlements	(1,714)	(110)	0
Asset impairments and related charges	3,454	327	120
Depreciation	2,225	2,074	2,137
Amortization	4,755	6,726	4,089
Share-based compensation	3,140	2,119	1,638
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	(1,619)	0	0
Deferred income taxes	(371)	(178)	(244)
Change in cash surrender value of company owned life insurance policies	(57)	(600)	(107)
Excess tax benefit from equity awards	(14)	(37)	0
Changes in operating assets and liabilities:
Accounts receivable	(1,935)	(7,846)	(741)
Inventories	(171)	380	426
Prepaid expense	(526)	(498)	(801)
Accounts payable	5,528	1,073	1,595
Deferred revenue	1,146	2,784	(5,046)
Accrued liabilities	(3,868)	1,624	(3,170)
Income taxes receivable	(823)	(2,702)	(2,960)
Other changes, net	(176)	(508)	(258)
Net cash provided by (used in) operating activities from continuing operations	(2,186)	1,384	(13,050)
Net cash (used in) provided by operating activities from discontinued operations	0	1,311	(2,345)
Net cash provided by (used in) operating activities	(2,186)	73	(10,705)
Proceeds from sale of business units	809	35,846	0
Cash paid for acquisitions, net	(3,750)	1,812	0
Payments to Acquire Marketable Securities	(10,240)	0	0
Proceeds from sale of marketable securities	10,107	0	4,347
Capital expenditures	(4,650)	(4,023)	(2,532)
Capitalized software development costs	(15,813)	(12,200)	(3,906)
Additional (investments in) proceeds from corporate-owned life insurance policies	1,905	(87)	(108)
Net cash provided by (used in) investing activities from continuing operations	(21,632)	17,724	(2,199)
Net cash used in investing activities from discontinued operations	0	(155)	(854)
Net cash provided by (used in) investing activities	(21,632)	17,569	(3,053)
Financing activities
Principal payments under long-term obligations	(144)	(177)	(289)
Exercise of employee stock options	102	169	67
Repurchase of common shares to satisfy employee tax withholding and option price	(373)	(912)	(278)
Excess tax benefit from equity awards	14	37	0
Net cash used in financing activities from continuing operations	(401)	(883)	(500)
Net cash used in financing activities from discontinued operations	0	(80)	(377)
Net cash used in financing activities	(401)	(963)	(877)
Effect of exchange rate changes on cash	(280)	(44)	(21)
Cash flows provided by (used in) continuing operations	(24,499)	18,181	(15,770)
Cash flows (used in) provided by discontinued operations	0	(1,546)	1,114
Net increase (decrease) in cash and cash equivalents	(24,499)	16,635	(14,656)
Cash and cash equivalents at beginning of period	99,566	82,931	97,587
Cash and cash equivalents at end of period	75,067	99,566	82,931
Less cash presented in current assets of discontinued operations on balance sheet	0	0	487
Cash and cash equivalents at end of period - continuing operations	$ 75,067	$ 99,566	$ 82,444